FyoniBio at OCT DACH – Outsourcing in Clinical Trials DACH

The OCT DACH is providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies.

This event will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over two days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.

Why Join?

• Focused conference for the DACH pharma market– Unlike other conferences, the event specifically focuses on the local pharma industry in Switzerland, Germany and Austria, highlighting the current challenges and exciting innovations and opportunities within the market
• Excellent speaker line up – Senior level speakers from leading organisations such as Roche, AstraZeneca and Novartis along with exciting biotechs like Medac and Medigene
• Great and Diverse Sessions – OCT DACH covers a variety of topics ranging from updated EMA Guidance to Direct to Patient and Data management innovation to CRO relationship
• Unbeatable Networking Opportunities –Meet and network with over 150 senior industry decision makers during our dedicated networking breaks, round tables and interactive sessions

Be sure to stop by at booth 41 of FyoniBio GmbH where Hans Baumeister, Managing Director, is there to enthusiastically engage with you on your new innovative projects. He will be there to discuss your needs for customized PK, ADA and biomarker assays in your upcoming clinical development programs.
FyoniBio is a member of the Bio-PAT network.

Agenda
Registration
Speakers

iCal exportieren